DETECTION OF BONE-MARROW INVOLVEMENT IN PEDIATRIC SOLID TUMORS AS DIAGNOSIS - METHODS, RESULTS, AND INTERPRETATION

被引:1
作者
PEIN, F
HARTMANN, O
SAKIROGLU, C
BAYLE, C
TERRIERLACOMBE, MJ
VALTEAUCOUANET, D
LUMBROSO, J
OBERLIN, O
COUANET, D
PATTE, C
BRUGIERES, L
LEMERLE, J
机构
[1] INST GUSTAVE ROUSSY,HEMATOCYTOL LAB,F-94800 VILLEJUIF,FRANCE
[2] INST GUSTAVE ROUSSY,ANAT PATHOL LAB,F-94800 VILLEJUIF,FRANCE
[3] INST GUSTAVE ROUSSY,NUCL MED SERV,F-94800 VILLEJUIF,FRANCE
[4] INST GUSTAVE ROUSSY,SERV RADIODIAGNOST,F-94800 VILLEJUIF,FRANCE
来源
ARCHIVES DE PEDIATRIE | 1995年 / 2卷 / 06期
关键词
SOLID TUMOR; BONE MARROW INVOLVEMENT; DIAGNOSIS; CHILD;
D O I
10.1016/0929-693X(96)81205-X
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The assessment of bone marrow involvement by tumor cells remains an essential problem at diagnosis in pediatric solid rumors. Besides the conventional cytological and histological methods, some modern cell density separation techniques have been described in order to improve the detection of minimal or scattered bone marrow involvement. Immunological or generical (molecular biology) tools can be used for the recognition of separated cells. In terms of investigations, MRI and MIBG radionucleide scan, although giving no definite proof; have the ability to macroscopically study the scattering of bone marrow invasion in the particular case of neuroblastoma. In some pediatric rumors, especially neuroblastomas and non Hodgkin lymphomas, an extensive bone marrow investigation is mandatory at diagnosis. Such an investigation is only necessary in case of particular criteria at diagnosis of Hodgkin's disease, Ewing' sarcomas, rhabdomyosarcomas and retinoblastomas. All other pediatric solid tumors do not need to be investigated in terms of bone marrow involvement at diagnosis, with the exceptions of advanced disseminated disease or if an autologous bone marrow transplantation is planned.
引用
收藏
页码:580 / 588
页数:9
相关论文
共 37 条
  • [1] DETECTION OF BONE-MARROW INVOLVEMENT BY NEURO-BLASTOMA - COMPARISON OF 2 CYTOLOGICAL METHODS
    BAYLE, C
    ALLARD, T
    RODARY, C
    VANDERPLANCKE, J
    HARTMANN, O
    LEMERLE, J
    [J]. EUROPEAN PAEDIATRIC HAEMATOLOGY AND ONCOLOGY, 1985, 2 (03): : 123 - 128
  • [2] BERGERON C, 1993, MED PEDIATR ONCOL, V8
  • [3] AUDIT OF BONE-MARROW TREPHINES
    BISHOP, PW
    MCNALLY, K
    HARRIS, M
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (12) : 1105 - 1108
  • [4] Bouvier J F, 1988, Prog Clin Biol Res, V271, P707
  • [5] BRUGIERES L, 1989, ENCY CANCER CANCER E, P332
  • [6] PLASTIC SECTIONS AND ULTRASTRUCTURAL TECHNIQUES IN THE EVALUATION OF BONE-MARROW PATHOLOGY
    BURNS, WA
    YOOK, CR
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1988, 2 (04) : 525 - 536
  • [7] IMMUNOHISTOCHEMICAL DEMONSTRATION OF NEURON SPECIFIC ENOLASE IN BONE-MARROW INFILTRATED BY NEUROBLASTOMA
    CAILLAUD, JM
    MARTINEZMADRIGAL, F
    HARTMANN, O
    CARLU, C
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1991, 44 (04) : 309 - 312
  • [8] CANGIR A, 1990, CANCER-AM CANCER SOC, V66, P887, DOI 10.1002/1097-0142(19900901)66:5<887::AID-CNCR2820660513>3.0.CO
  • [9] 2-R
  • [10] CHEUNG NV, 1988, ADV NEUROBLASTOMA RE, V271, P595